Serum Antibody Responses after Intradermal Vaccination against Influenza
Open Access
- 25 November 2004
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (22), 2286-2294
- https://doi.org/10.1056/nejmoa043555
Abstract
If found to be safe and immunogenic, reduced doses of influenza vaccine given by the intradermal route could increase the number of available doses of vaccine.This publication has 14 references indexed in Scilit:
- Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: A comparison with the intramuscular vaccinationAmerican Journal of Kidney Diseases, 2004
- Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adultsVaccine, 2002
- Comparison of Higher-Dose Intradermal Hepatitis B Vaccination to Standard Intramuscular Vaccination of Healthcare WorkersInfection Control & Hospital Epidemiology, 2000
- Antibody Response After a Four‐Site Intradermal Booster Vaccination with Cell‐Culture Rabies VaccineClinical Infectious Diseases, 1999
- Intradermal hepatitis B vaccination in a large hospital employee populationVaccine, 1991
- Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year resultsArchiv für die gesamte Virusforschung, 1986
- Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategyJama-Journal Of The American Medical Association, 1985
- INTRADERMAL HEPATITIS B VIRUS VACCINE: IMMUNOGENICITY AND SIDE-EFFECTS IN ADULTSThe Lancet, 1983
- The Immunizing Effect of Influenza A/New Jersey/76 (Hsw1N1) Virus Vaccine Administered Intradermally and Intramuscularly to AdultsThe Journal of Infectious Diseases, 1977
- Letter: Intradermal influenza vaccination.BMJ, 1974